Your browser doesn't support javascript.
loading
Durable ibrutinib responses in relapsed/refractory marginal zone lymphoma: long-term follow-up and biomarker analysis.
Noy, Ariela; de Vos, Sven; Coleman, Morton; Martin, Peter; Flowers, Christopher R; Thieblemont, Catherine; Morschhauser, Franck; Collins, Graham P; Ma, Shuo; Peles, Shachar; Smith, Stephen D; Barrientos, Jacqueline C; Chong, Elizabeth; Wu, Shiquan; Cheung, Leo W-K; Kwei, Kevin; Hauns, Bernhard; Arango-Hisijara, Israel; Chen, Robert.
Afiliação
  • Noy A; Memorial Sloan Kettering Cancer Center, New York, NY.
  • de Vos S; Weill Cornell Medical College, New York, NY.
  • Coleman M; David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA.
  • Martin P; Weill Cornell Medical College, New York, NY.
  • Flowers CR; Weill Cornell Medical College, New York, NY.
  • Thieblemont C; Winship Cancer Institute, Emory University, Atlanta, GA.
  • Morschhauser F; Hôpital Saint-Louis, Paris, France.
  • Collins GP; Hôpital Claude Huriez, Centre Hospitalier Régional Universitaire de Lille, Lille, France.
  • Ma S; Oxford Cancer and Haematology Centre, Churchill Hospital, Oxford, United Kingdom.
  • Peles S; Robert H. Lurie Comprehensive Cancer Center, Northwestern University Feinberg School of Medicine, Chicago, IL.
  • Smith SD; Florida Cancer Specialists, Atlantis, FL.
  • Barrientos JC; University of Washington/Fred Hutchinson Cancer Research Center, Seattle, WA.
  • Chong E; Division of Medical Oncology and Hematology, Northwell Health Cancer Institute, New Hyde Park, NY.
  • Wu S; Pharmacyclics LLC, an AbbVie Company, Sunnyvale, CA; and.
  • Cheung LW; Pharmacyclics LLC, an AbbVie Company, Sunnyvale, CA; and.
  • Kwei K; Pharmacyclics LLC, an AbbVie Company, Sunnyvale, CA; and.
  • Hauns B; Pharmacyclics LLC, an AbbVie Company, Sunnyvale, CA; and.
  • Arango-Hisijara I; Pharmacyclics LLC, an AbbVie Company, Sunnyvale, CA; and.
  • Chen R; Pharmacyclics LLC, an AbbVie Company, Sunnyvale, CA; and.
Blood Adv ; 4(22): 5773-5784, 2020 11 24.
Article em En | MEDLINE | ID: mdl-33227125

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Linfoma de Zona Marginal Tipo Células B Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Blood Adv Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Linfoma de Zona Marginal Tipo Células B Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Blood Adv Ano de publicação: 2020 Tipo de documento: Article